$Portola制药(PTLA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-12 AccNo: 0000902219-18-000417 Size: 37 KB 网页链接
$Portola制药(PTLA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-12 AccNo: 0000932471-18-004426 Size: 45 KB 网页链接
$Portola制药(PTLA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-08 AccNo: 0000902219-18-000368 Size: 37 KB 网页链接
$Portola制药(PTLA)$ 8-K - Current report Filed: 2018-02-06 AccNo: 0001193125-18-033281 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Portola制药(PTLA)$ 8-K - Current report Filed: 2018-02-06 AccNo: 0001193125-18-033281 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Portola制药(PTLA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-29 AccNo: 0000215457-18-003619 Size: 13 KB 网页链接
$Portola制药(PTLA)$ 内部交易: 2017-12-15,Director,Wolff Henry Ward ,卖出,12000普通股, $47.00
$Portola制药(PTLA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-11-09 AccNo: 0001193125-17-338978 Size: 85 KB 网页链接
$Portola制药(PTLA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-09 AccNo: 0001564590-17-022948 Size: 7 MB 网页链接
$Portola制药(PTLA)$ 8-K - Current report Filed: 2017-11-06 AccNo: 0001193125-17-334357 Size: 79 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接